Boehringer Ingelheim
  • About Jardiance
  • About Metabolic
  • Resources
  • Contact
za
Login

Jardiance
 
 
 

Efficacy

Efficay
Efficacy
38% relative risk reduction in CV death with Jardiance

01:01

38% relative risk reduction in CV death with Jardiance
CV Reduction was generally consistent across baseline HbA1c

0:58

CV Reduction was generally consistent across baseline HbA1c
Patients could live longer with Jardiance

0:59

Patients could live longer with Jardiance
Relative risk reduction of CV death by more than 1/3

01:01

Relative risk reduction of CV death by more than 1/3
Early impact on risk reduction of CV death

01:01

Early impact on risk reduction of CV death
32% Relative risk reduction in all-cause mortality

01:01

32% Relative risk reduction in all-cause mortality
Reduction of CV death was achieved ontop of standard of care

01:03

Reduction of CV death was achieved ontop of standard of care
35% Relative reduction in hospitilization for heart failure

01:01

35% Relative reduction in hospitilization for heart failure

Production date: June 2020
  • Therapeutic Area
  • Metabolic
  • Cardiovascular
  • Respiratory
  • Resources
  • Videos
  • Clinical Studies
  • BI Learning
  • Site map
  • Privacy
  • Terms of use
  • Contact
  • Change country

© 2010-2021
Boehringer Ingelheim International GmbH.
All rights reserved.